BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu W, Wang Y, Löbmann K, Grohganz H, Rades T. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems. Mol Pharm 2019;16:1294-304. [PMID: 30624075 DOI: 10.1021/acs.molpharmaceut.8b01229] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang P, Wang Y, Suo Z, Zhai Y, Li H. Cyclodextrin and its derivatives as effective excipients for amorphous ulipristal acetate systems. RSC Adv 2022;12:9170-8. [PMID: 35424854 DOI: 10.1039/d1ra09420c] [Reference Citation Analysis]
2 Ornik J, Knoth D, Koch M, Keck CM. Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms® and tablets made from paper. Int J Pharm 2020;581:119253. [PMID: 32217156 DOI: 10.1016/j.ijpharm.2020.119253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
3 Bolla G, Sarma B, Nangia AK. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs. Chem Rev 2022. [PMID: 35642550 DOI: 10.1021/acs.chemrev.1c00987] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Taylor LS, Braun DE, Steed JW. Crystals and Crystallization in Drug Delivery Design. Crystal Growth & Design 2021;21:1375-7. [DOI: 10.1021/acs.cgd.0c01592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
5 Taylor LS, Braun DE, Steed JW. Crystals and Crystallization in Drug Delivery Design. Mol Pharm 2021;18:751-3. [PMID: 33594892 DOI: 10.1021/acs.molpharmaceut.0c01157] [Reference Citation Analysis]
6 Xiao H, Guo Y, Liu H, Liu Y, Wang Y, Li C, Císař J, Škoda D, Kuřitka I, Guo L, Sedlařík V. Structure-based design of charge-conversional drug self-delivery systems for better targeted cancer therapy. Biomaterials 2020;232:119701. [DOI: 10.1016/j.biomaterials.2019.119701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
7 Li J, Duggirala NK, Kumar NSK, Su Y, Suryanarayanan R. Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations. Mol Pharm 2022. [PMID: 35797094 DOI: 10.1021/acs.molpharmaceut.2c00307] [Reference Citation Analysis]
8 Kumar A, Nanda A. In-silico methods of cocrystal screening: A review on tools for rational design of pharmaceutical cocrystals. Journal of Drug Delivery Science and Technology 2021;63:102527. [DOI: 10.1016/j.jddst.2021.102527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wong SN, Chan SWS, Peng X, Xuan B, Lee HW, Tong HHY, Chow SF. Effects of the Glass-Forming Ability and Annealing Conditions on Cocrystallization Behaviors via Rapid Solvent Removal: A Case Study of Voriconazole. Pharmaceutics 2020;12:E1209. [PMID: 33327381 DOI: 10.3390/pharmaceutics12121209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Omori M, Yamamoto H, Matsui F, Sugano K. Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers. Pharm Res 2022. [PMID: 35194718 DOI: 10.1007/s11095-022-03209-x] [Reference Citation Analysis]
11 Roca-paixão L, Correia NT, Affouard F. Affinity prediction computations and mechanosynthesis of carbamazepine based cocrystals. CrystEngComm 2019;21:6991-7001. [DOI: 10.1039/c9ce01160a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chen X, Li D, Duan Y, Huang Y. Characterization of co-amorphous sinomenine-tranilast systems with strong intermolecular interactions and sustained release profiles. Journal of Drug Delivery Science and Technology 2022;71:103296. [DOI: 10.1016/j.jddst.2022.103296] [Reference Citation Analysis]
13 Wang Y, Rades T, Grohganz H. Effects of polymer addition on the non-strongly interacting binary co-amorphous system carvedilol-tryptophan. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121625] [Reference Citation Analysis]
14 Liu J, Grohganz H, Löbmann K, Rades T, Hempel NJ. Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics 2021;13:389. [PMID: 33804159 DOI: 10.3390/pharmaceutics13030389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zeng X, Zhang Y, Xu X, Chen Z, Ma L, Wang Y, Guo X, Li J, Wang X. Construction of pH-sensitive targeted micelle system co-delivery with curcumin and dasatinib and evaluation of anti-liver cancer. Drug Deliv 2022;29:792-806. [PMID: 35261298 DOI: 10.1080/10717544.2022.2048132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kim DH, Kim YW, Tin YY, Soe MT, Ko BH, Park SJ, Lee JW. Recent Technologies for Amorphization of Poorly Water-Soluble Drugs. Pharmaceutics 2021;13:1318. [PMID: 34452279 DOI: 10.3390/pharmaceutics13081318] [Reference Citation Analysis]
17 Han J, Li L, Yu Q, Zheng D, Song Y, Zhang J, Gao Y, Heng W, Qian S, Pang Z. Self-gelation involved in the transformation of resveratrol and piperine from a co-amorphous system into a co-crystal system. CrystEngComm. [DOI: 10.1039/d2ce00671e] [Reference Citation Analysis]
18 Li H, Zhang M, Xiong L, Feng W, Williams RO 3rd. Bioavailability Improvement of Carbamazepine via Oral Administration of Modified-Release Amorphous Solid Dispersions in Rats. Pharmaceutics 2020;12:E1023. [PMID: 33114739 DOI: 10.3390/pharmaceutics12111023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Tawfeek HM, Chavan T, Kunda NK. Effect of Spray Drying on Amorphization of Indomethacin Nicotinamide Cocrystals; Optimization, Characterization, and Stability Study. AAPS PharmSciTech 2020;21:181. [PMID: 32607628 DOI: 10.1208/s12249-020-01732-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Gröls JR, Castro-dominguez B. Intelligent Mechanochemical Design of Co-Amorphous Mixtures. Crystal Growth & Design 2022;22:2989-96. [DOI: 10.1021/acs.cgd.1c01442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Han J, Wei Y, Lu Y, Wang R, Zhang J, Gao Y, Qian S. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update. Expert Opinion on Drug Delivery 2020;17:1411-35. [DOI: 10.1080/17425247.2020.1796631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
22 Zhang M, Suo Z, Peng X, Gan N, Zhao L, Tang P, Wei X, Li H. Microcrystalline cellulose as an effective crystal growth inhibitor for the ternary Ibrutinib formulation. Carbohydr Polym 2020;229:115476. [PMID: 31826488 DOI: 10.1016/j.carbpol.2019.115476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]